These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21404328)

  • 1. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking.
    Nkansah MK; Thakral D; Shapiro EM
    Magn Reson Med; 2011 Jun; 65(6):1776-85. PubMed ID: 21404328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking.
    Granot D; Nkansah MK; Bennewitz MF; Tang KS; Markakis EA; Shapiro EM
    Magn Reson Med; 2014 Mar; 71(3):1238-50. PubMed ID: 23568825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cryoprotection on the use of PLGA encapsulated iron oxide nanoparticles for magnetic cell labeling.
    Tang KS; Hashmi SM; Shapiro EM
    Nanotechnology; 2013 Mar; 24(12):125101. PubMed ID: 23459030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-co-glycolic acid) encapsulated gadolinium oxide nanoparticles for MRI-based cell tracking.
    Bennewitz MF; Williams SS; Nkansah MK; Shapiro EM
    J Nanosci Nanotechnol; 2013 Jun; 13(6):3778-83. PubMed ID: 23862407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI.
    Doiron AL; Chu K; Ali A; Brannon-Peppas L
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17232-7. PubMed ID: 18796605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
    Okassa LN; Marchais H; Douziech-Eyrolles L; Hervé K; Cohen-Jonathan S; Munnier E; Soucé M; Linassier C; Dubois P; Chourpa I
    Eur J Pharm Biopharm; 2007 Aug; 67(1):31-8. PubMed ID: 17289360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus.
    Zhang Y; Zhou J; Guo D; Ao M; Zheng Y; Wang Z
    Int J Nanomedicine; 2013; 8():3745-56. PubMed ID: 24124363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
    Shanavas A; Sasidharan S; Bahadur D; Srivastava R
    J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional poly (lactide-co-glycolide) nanoparticles for luminescence/magnetic resonance imaging and photodynamic therapy.
    Lee DJ; Park GY; Oh KT; Oh NM; Kwag DS; Youn YS; Oh YT; Park JW; Lee ES
    Int J Pharm; 2012 Sep; 434(1-2):257-63. PubMed ID: 22664459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
    Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
    J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive Hybrid Particles from Poly(D,L-lactide-co-glycolide) Nanoparticle Stabilized Lipid Droplets.
    Joyce P; Whitby CP; Prestidge CA
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17460-70. PubMed ID: 26181279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents.
    Ratzinger G; Agrawal P; Körner W; Lonkai J; Sanders HM; Terreno E; Wirth M; Strijkers GJ; Nicolay K; Gabor F
    Biomaterials; 2010 Nov; 31(33):8716-23. PubMed ID: 20797782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of hybrid multimodal poly(lactic-co-glycolic acid) polymer nanoparticles for neutrophil labeling, imaging and tracking.
    Qiu Y; Palankar R; Echeverría M; Medvedev N; Moya SE; Delcea M
    Nanoscale; 2013 Dec; 5(24):12624-32. PubMed ID: 24177321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.
    Semete B; Booysen L; Lemmer Y; Kalombo L; Katata L; Verschoor J; Swai HS
    Nanomedicine; 2010 Oct; 6(5):662-71. PubMed ID: 20230912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined magnetic field and iron oxide-PLGA composite particles: Effective protein antigen delivery and immune stimulation in dendritic cells.
    Saengruengrit C; Ritprajak P; Wanichwecharungruang S; Sharma A; Salvan G; Zahn DRT; Insin N
    J Colloid Interface Sci; 2018 Jun; 520():101-111. PubMed ID: 29529457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging.
    Li Q; Li C; Tong W
    J Nanosci Nanotechnol; 2016 Jun; 16(6):5569-76. PubMed ID: 27427598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
    Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
    J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
    Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
    J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and characterisation of poly(lactide-co-glycolide) small particulate systems for the delivery of immunostimulant CpG oligonucleotide.
    Shakweh M; Fattal E
    J Nanosci Nanotechnol; 2006; 6(9-10):2811-20. PubMed ID: 17048487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.
    Guo C; Gemeinhart RA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):597-604. PubMed ID: 18602994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.